Precision’s specialty assays can support you from preclinical through pivotal studies. Our expertise includes cell biology, tissue profiling, sample processing, and molecular capabilities. Because you need high-quality, accurate study results, we deliver meticulous sample handling and sophisticated global logistics—and operate under GxP, ISO 9001, ISO 13485, College of American Pathologists (CAP), and Clinical Laboratory Improvement Amendments (CLIA).
Clinical immune monitoring. We offer one of the broadest arrays of immune monitoring solutions in the industry. Our technology platforms include flow cytometry, ELISpot, NanoString, and multiplexed cytokine assessments that can be implemented consistently at scale. Of note, we offer epigenetic-based immune monitoring through our proprietary offering, Epiontis ID, a rapid, cost-effective technology that delivers robust immune status data.
Explore immune monitoring solutions
Discover Epiontis ID
Tumor and tissue biopsy and liquid biopsy services. Precision offers advanced solutions for tissue and liquid biopsy profiling. We can design assays and validate biomarkers for immune-oncology applications including standard immunohistochemistry and multiplex immunofluorescence image analysis. We also offer assays using our proprietary ApoStream® liquid biopsy technology, which can generate both phenotypic and genomic information from the same biopsy sample. ApoStream allows for the capture, enrichment, and subsequent analysis of CTCs and other rare cells without the need for labels or antibodies.
Learn more about the specifics of our tumor and tissue biopsy and liquid biopsy services.
Global biorepositories and biobanking. Precision manages 25 million + biospecimens—with samples from over 100 active clinical trials on 6 continents. We house samples in LN 2, at -80; -20; +4°C; and ambient temperature—all conditions that are replicated in our biorepositories worldwide to ensure accurate, consistent research results.
Consistent specimen collection. With real-time sample processing occurring in over 50 countries on 6 continents, we are able to manage the sample from draw to assay, streamlining handling and ensuring sample preservation, integrity, and consistency.
Bioanalytical services for large molecules. Our renowned scientific leadership helped establish the basis of FDA and EMA guidance in immunogenicity. Our passions include assays for PEGylated proteins, ADCs, biospecifics, gene therapies, CAR-T’s novel techniques such as drug-specific IgE assays, and assessments of complement activation.